杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2011/03/17 | 1,260 | 1,369 | 1,250 | 1,355 | +35 | +2.7% | 314,000 |
| 2011/03/16 | 1,261 | 1,346 | 1,256 | 1,320 | +29 | +2.2% | 455,000 |
| 2011/03/15 | 1,372 | 1,372 | 1,220 | 1,291 | -111 | -7.9% | 339,000 |
| 2011/03/14 | 1,380 | 1,484 | 1,353 | 1,402 | -90 | -6% | 269,000 |
| 2011/03/11 | 1,493 | 1,510 | 1,486 | 1,492 | -17 | -1.1% | 271,000 |
| 2011/03/10 | 1,515 | 1,523 | 1,508 | 1,509 | -15 | -1% | 173,000 |
| 2011/03/09 | 1,516 | 1,539 | 1,507 | 1,524 | +9 | +0.6% | 271,000 |
| 2011/03/08 | 1,514 | 1,527 | 1,514 | 1,515 | +5 | +0.3% | 163,000 |
| 2011/03/07 | 1,530 | 1,530 | 1,500 | 1,510 | -18 | -1.2% | 267,000 |
| 2011/03/04 | 1,501 | 1,536 | 1,495 | 1,528 | +8 | +0.5% | 502,000 |
| 2011/03/03 | 1,494 | 1,531 | 1,480 | 1,520 | +79 | +5.5% | 746,000 |
| 2011/03/02 | 1,467 | 1,472 | 1,439 | 1,441 | -33 | -2.2% | 578,000 |
| 2011/03/01 | 1,492 | 1,521 | 1,444 | 1,474 | -15 | -1% | 756,000 |
| 2011/02/28 | 1,492 | 1,492 | 1,474 | 1,489 | +9 | +0.6% | 201,000 |
| 2011/02/25 | 1,509 | 1,509 | 1,468 | 1,480 | -13 | -0.9% | 317,000 |
| 2011/02/24 | 1,502 | 1,510 | 1,485 | 1,493 | -11 | -0.7% | 197,000 |
| 2011/02/23 | 1,514 | 1,531 | 1,503 | 1,504 | -4 | -0.3% | 179,000 |
| 2011/02/22 | 1,523 | 1,527 | 1,505 | 1,508 | -17 | -1.1% | 171,000 |
| 2011/02/21 | 1,522 | 1,535 | 1,522 | 1,525 | -13 | -0.8% | 214,000 |
| 2011/02/18 | 1,525 | 1,547 | 1,508 | 1,538 | +17 | +1.1% | 283,000 |
| 2011/02/17 | 1,540 | 1,540 | 1,519 | 1,521 | -21 | -1.4% | 509,000 |
| 2011/02/16 | 1,564 | 1,564 | 1,536 | 1,542 | -22 | -1.4% | 225,000 |
| 2011/02/15 | 1,539 | 1,573 | 1,533 | 1,564 | +15 | +1% | 159,000 |
| 2011/02/14 | 1,559 | 1,569 | 1,543 | 1,549 | -15 | -1% | 282,000 |
| 2011/02/10 | 1,566 | 1,575 | 1,555 | 1,564 | -3 | -0.2% | 282,000 |
| 2011/02/09 | 1,544 | 1,578 | 1,544 | 1,567 | +33 | +2.2% | 287,000 |
| 2011/02/08 | 1,536 | 1,549 | 1,533 | 1,534 | -3 | -0.2% | 161,000 |
| 2011/02/07 | 1,523 | 1,550 | 1,518 | 1,537 | +17 | +1.1% | 342,000 |
| 2011/02/04 | 1,513 | 1,542 | 1,510 | 1,520 | +6 | +0.4% | 251,000 |
| 2011/02/03 | 1,503 | 1,524 | 1,495 | 1,514 | +11 | +0.7% | 156,000 |
| 2011/02/02 | 1,499 | 1,518 | 1,488 | 1,503 | +17 | +1.1% | 262,000 |
| 2011/02/01 | 1,508 | 1,515 | 1,477 | 1,486 | -20 | -1.3% | 279,000 |
| 2011/01/31 | 1,495 | 1,514 | 1,495 | 1,506 | +12 | +0.8% | 269,000 |
| 2011/01/28 | 1,505 | 1,507 | 1,490 | 1,494 | -10 | -0.7% | 225,000 |
| 2011/01/27 | 1,488 | 1,520 | 1,488 | 1,504 | +13 | +0.9% | 353,000 |
| 2011/01/26 | 1,495 | 1,499 | 1,483 | 1,491 | -8 | -0.5% | 155,000 |
| 2011/01/25 | 1,493 | 1,508 | 1,479 | 1,499 | +12 | +0.8% | 276,000 |
| 2011/01/24 | 1,483 | 1,487 | 1,469 | 1,487 | +22 | +1.5% | 116,000 |
| 2011/01/21 | 1,471 | 1,531 | 1,463 | 1,465 | +12 | +0.8% | 595,000 |
| 2011/01/20 | 1,450 | 1,460 | 1,440 | 1,453 | +3 | +0.2% | 260,000 |
| 2011/01/19 | 1,467 | 1,475 | 1,445 | 1,450 | -16 | -1.1% | 266,000 |
| 2011/01/18 | 1,465 | 1,475 | 1,461 | 1,466 | +2 | +0.1% | 163,000 |
| 2011/01/17 | 1,485 | 1,489 | 1,455 | 1,464 | -28 | -1.9% | 356,000 |
| 2011/01/14 | 1,443 | 1,505 | 1,442 | 1,492 | +44 | +3% | 638,000 |
| 2011/01/13 | 1,431 | 1,455 | 1,425 | 1,448 | +14 | +1% | 283,000 |
| 2011/01/12 | 1,437 | 1,440 | 1,421 | 1,434 | +1 | +0.1% | 260,000 |
| 2011/01/11 | 1,407 | 1,439 | 1,405 | 1,433 | +21 | +1.5% | 336,000 |
| 2011/01/07 | 1,420 | 1,421 | 1,400 | 1,412 | -9 | -0.6% | 289,000 |
| 2011/01/06 | 1,429 | 1,429 | 1,418 | 1,421 | -9 | -0.6% | 152,000 |
| 2011/01/05 | 1,417 | 1,430 | 1,416 | 1,430 | +13 | +0.9% | 178,000 |
3351～
3400
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ＪＣＲファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| 栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム
